For research and educational purposes only. Not medical advice.

Leuprolide Reference

Educational, not medical advice reference for Leuprolide: Reproductive, Hormonal; regulatory status, evidence posture, source review, and schedu…

Reference summary

Leuprolide is a label-verified GnRH agonist depot with decades of approved-label evidence in oncology and endocrinology. pepSmart surfaces label-reference content only.

Regulatory and posture

Categories
Reproductive, Hormonal
Aliases
Lupron Depot, Eligard, GnRH agonist
Evidence posture
human - Oncology / endocrinology drug. Prescription-only, clinician-managed; off-label or self-administered use carries serious harm potential including bone-density loss, cardiovascular events, and oncology-specific concerns.
Regulatory status
FDA-approved prescription medication (Lupron Depot, Eligard). Indications include advanced prostate cancer, endometriosis, central precocious puberty, and uterine fibroids. Prescription-only and clinician-managed.
Content review status
label verified

Selected public sources

Related tools